Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Solvac is a prominent Belgian holding company that serves as the primary investment vehicle for the descendants of Ernest Solvay, the founder of the global chemical group Solvay. Listed on Euronext Brussels, the company's assets consist almost exclusively of a significant stake (approximately 30%) in both Solvay SA and Syensqo SA. While Solvac itself does not conduct operational research or drug development, it has a deep historical connection to the life sciences through Solvay's former pharmaceutical division and Syensqo's current focus on specialty materials for healthcare applications, such as medical devices and implants. The company acts as a long-term reference shareholder, providing strategic stability and oversight to its core industrial holdings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Solvac.